Cabot (NYSE:CBT) Announces Earnings Results, Misses Estimates By $0.01 EPS

Cabot (NYSE:CBT) posted its quarterly earnings results on Monday. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01), Briefing.com reports. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the firm earned $1.65 EPS. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Stock Performance

NYSE:CBT opened at $108.88 on Wednesday. The stock has a market cap of $5.97 billion, a P/E ratio of 12.95, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. The company has a current ratio of 2.22, a quick ratio of 1.45 and a debt-to-equity ratio of 0.72. The stock’s 50-day moving average is $108.41 and its 200-day moving average is $101.13. Cabot has a 1-year low of $66.02 and a 1-year high of $117.14.

Insider Transactions at Cabot

In other news, CEO Sean D. Keohane sold 25,617 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the sale, the chief executive officer now directly owns 331,174 shares in the company, valued at approximately $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CEO Sean D. Keohane sold 25,617 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the sale, the chief executive officer now directly owns 331,174 shares in the company, valued at approximately $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Jeff Ji Zhu sold 1,201 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $106.19, for a total value of $127,534.19. Following the sale, the executive vice president now owns 96,000 shares in the company, valued at approximately $10,194,240. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,665 shares of company stock worth $4,986,299. Insiders own 3.07% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on CBT. UBS Group dropped their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a research note on Tuesday, August 6th. JPMorgan Chase & Co. lifted their target price on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. Finally, Mizuho lifted their target price on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research report on Tuesday. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Cabot presently has an average rating of “Hold” and an average target price of $105.00.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.